| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5824408 | Clinical Therapeutics | 2016 | 7 Pages |
Abstract
The relative bioavailability of MPH ERCT 40 mg, based on the exposure (AUC), was comparable to that of IR MPH 40 mg administered in 2 equal doses of 20 mg 6 hours apart. Both formulations were generally well tolerated.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Richat PhD, Donna PhD, Faith PharmD, Heidi PharmD, Sally A. MD, PhD,